- Home
- EPC vs EVO Comparison
EPC vs EVO Comparison
Compare EPC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPC
- EVO
- Stock Information
- Founded
- EPC 1999
- EVO 1993
- Country
- EPC United States
- EVO Germany
- Employees
- EPC N/A
- EVO N/A
- Industry
- EPC Package Goods/Cosmetics
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- EPC Consumer Discretionary
- EVO Health Care
- Exchange
- EPC Nasdaq
- EVO Nasdaq
- Market Cap
- EPC 1.5B
- EVO 1.6B
- IPO Year
- EPC 2000
- EVO 2021
- Fundamental
- Price
- EPC $31.70
- EVO $3.23
- Analyst Decision
- EPC Buy
- EVO Buy
- Analyst Count
- EPC 7
- EVO 2
- Target Price
- EPC $36.57
- EVO $5.90
- AVG Volume (30 Days)
- EPC 522.8K
- EVO 107.8K
- Earning Date
- EPC 05-07-2025
- EVO 05-21-2025
- Dividend Yield
- EPC 1.89%
- EVO N/A
- EPS Growth
- EPC N/A
- EVO N/A
- EPS
- EPC 1.86
- EVO N/A
- Revenue
- EPC $2,243,200,000.00
- EVO $866,665,179.00
- Revenue This Year
- EPC $0.68
- EVO $3.70
- Revenue Next Year
- EPC $2.12
- EVO $10.32
- P/E Ratio
- EPC $17.07
- EVO N/A
- Revenue Growth
- EPC N/A
- EVO N/A
- 52 Week Low
- EPC $26.65
- EVO $2.85
- 52 Week High
- EPC $41.50
- EVO $7.98
- Technical
- Relative Strength Index (RSI)
- EPC 59.14
- EVO 29.01
- Support Level
- EPC $29.16
- EVO $3.25
- Resistance Level
- EPC $29.92
- EVO $3.37
- Average True Range (ATR)
- EPC 0.68
- EVO 0.09
- MACD
- EPC 0.22
- EVO 0.00
- Stochastic Oscillator
- EPC 99.22
- EVO 13.44
About EPC Edgewell Personal Care Company
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.